Health Insurance (Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Amendment Determination 2013 (No. 1)

Administered by Department of Health, Disability and Ageing

Legislation au F2013L01158 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

Issued by the Authority of the Minister for Health and Ageing

Health Insurance Act 1973

Health Insurance (Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Amendment Determination 2013 (No.1)

Subsection 3C(1) of the Health Insurance Act 1973 (the Act) provides that the Minister may, by writing, determine that a health service not listed in the pathology services table (the Table) shall, in specified circumstance and for specified statutory provisions, be treated as if it were so listed.  This Table is set out in the Health Insurance (Pathology Services Table) Regulation which is remade each year. The Health Insurance (Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Amendment Determination 2012 (No. 1) (the Determination) amends the Health Insurance (Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Determination HS/01/06 (the Principal Determination) to reduce the fees of the diabetes monitoring pathology tests in the Principal Determination.

The Principal Determination enables Medicare benefits to be payable for two point of care pathology diagnostic tests (quantitation of glycosolated haemoglobin and urine albumin:creatinine ratio) used for the monitoring of diabetes in Aboriginal and Torres Strait Islander primary health care sites.  The Principal Determination allows these tests to be provided in Aboriginal and Torres Strait Islander communities where pathology testing may otherwise may not be possible.  The standard pathology provider eligibility requirements under the Act require pathology services to be provided at an accredited pathology laboratory by an approved pathology provider.  As most Aboriginal Medical Services and Aboriginal Controlled Community Health Services would not meet these requirements, they have been removed for the two point of care tests.  

To ensure quality of testing, the Principal Determination includes a requirement that a practitioner performing the test, or the organisation for which the practitioner works, must participate in the Quality Assurance in Aboriginal and Torres Strait Islander Medical Services Program (the QAAMS Program), an external quality assurance program. 

The QAAMS Program is funded by the Australian Government Department of Health and Ageing. The aim of the QAAMS Program is to provide education, training, quality assurance, quality control, and ongoing support services for point of care testing in Aboriginal Community Controlled Health Services and Aboriginal Medical Services.

The Pathology Funding Agreement (PFA) between the Commonwealth, the Royal College of Pathologists of Australasia, the Australian Association of Pathology Practices and the National Coalition of Public Pathologists governs the Australian Government outlays for pathology services. The PFA sets out agreed maximum and minimum Government outlays for each year of the agreement.

In December 2012, there was an Amendment Determination that amended the Principal Determination to reflect the changes to the pathology services table and the amounts payable through Medicare for items 73840 and 73844.  The fee for item 73840 will be reduced from $17.10 to $17.00, and the fee for item 73844 will be reduced from $20.50 to $20.35. 

The Determination amends the cessation date of the Principal Determination from 30 June 2013 to 30 June 2016, which was not revised by the last amendment Determination.  This will ensure the continued access to Medicare benefits for those Aboriginal and Torres Strait Islander health services enrolled in the QAAMS program.

Consultation

The decrease in fees for items in Groups 1 to 11 of the PST was negotiated with the other signatories to the PFA, namely the Royal College of Pathologists of Australasia, the Australian Association of Pathology Practices and the National Coalition of Public Pathologists. 

 

The Department of Human Services was consulted concerning the revised cessation date to consider any impact of the changes on their business operations, which was considered to be minimal given this is  a longstanding program.

 

This Determination commences on the day after it is registered.

This determination is a legislative instrument for the purposes of the Legislative Instruments Act 2003.


 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.